The DOI matches its Crossref record.
Differential Mechanisms of Neuroprotection by 17 β-Estradiol in Apoptotic versus Necrotic Neurodegeneration
Open accessAbstract
The major goal of this study was to compare mechanisms of the neuroprotective potential of 17 β-estradiol in two models for oxidative stress-independent apoptotic neuronal cell death with that in necrotic neuronal cell death in primary neuronal cultures derived from rat hippocampus, septum, or cortex. Neuronal apoptosis was induced either by staurosporine or ethylcholine aziridinium (AF64A), as models for necrotic cell death glutamate exposure or oxygen–glucose deprivation (OGD) were applied. Long-term (20 hr) pretreatment (0.1 μ m 17 β-estradiol) was neuroprotective in apoptotic neuronal cell death induced by AF64A (40 μ m) only in hippocampal and septal neuronal cultures and not in cortical cultures. The neuroprotective effect was blocked by the estrogen antagonists ICI 182,780 and tamoxifen and the phosphatidylinositol 3-kinase (PI3-K) inhibitor LY294002. In glutamate and OGD-induced neuronal damage, long-term pretreatment was not effective. In contrast, short-term (1 hr) pretreatment with 17 β-estradiol in the dose range of 0.5–1.0 μ m significantly reduced the release of lactate dehydrogenase and improved morphology of cortical cultures exposed to glutamate or OGD but was not effective in the AF64A model. Staurosporine-induced apoptosis was not prevented by either long- or short-term pretreatment. The strong expression of the estrogen receptor-α and the modulation of Bcl proteins by 17 β-estradiol in hippocampal and septal but not in cortical cultures indicates that the prevention of apoptotic, but not of necrotic, neuronal cell death by 17 β-estradiol possibly depends on the induction of Bcl proteins and the density of estrogen receptor-α.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Treatment of multiple sclerosis with the pregnancy hormone estriol
Sicotte, N. L., Liva, S. M., Klutch, R., Pfeiffer, P., Bouvier, S., Odesa, S., Wu, T. C. J., & Voskuhl, R. R. (2002) · Annals of Neurology · doi:10.1002/ana.10301 · Cited by 435
Innate Gender-based Proclivity in Response to Cytotoxicity and Programmed Cell Death Pathway
Du, L., Bayir, H., Lai, Y., Zhang, X., Kochanek, P. M., Watkins, S. C., Graham, S. H., & Clark, R. S. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405461200 · Cited by 352
Estrogen and ischemic neuroprotection: an integrated view
McCullough, L. D., & Hurn, P. D. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(03)00076-6 · Cited by 317
Immune Modulation in Multiple Sclerosis Patients Treated with the Pregnancy Hormone Estriol
Soldan, S. S., Retuerto, A. I. A., Sicotte, N. L., & Voskuhl, R. R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6267 · Cited by 278
Kapinya, K. J., Löwl, D., Fütterer, C., Maurer, M., Waschke, K. F., Isaev, N. K., & Dirnagl, U. (2002) · Stroke · doi:10.1161/01.str.0000020092.41820.58 · Cited by 272
Self-citation
Metadata
- Authors
- Harms, C., Lautenschlager, M., Bergk, A., Katchanov, J., Freyer, D., Kapinya, K., Herwig, U., Megow, D., Dirnagl, U., Weber, J. R., & Hörtnagl, H.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2001-04-15
- Volume
- 21
- Issue
- 8
- Pages
- 2600-2609
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W1903028880
- Cited by
- 161
- References
- 0
- FWCI
- 7.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differential Mechanisms of Neuroprotection by 17 β-Estradiol in Apoptotic versus Necrotic Neurodegeneration. https://app.cochat.ai/papers/10.1523/jneurosci.21-08-02600.2001
- The paper
- Harms, C., Lautenschlager, M., Bergk, A., Katchanov, J., Freyer, D., Kapinya, K., Herwig, U., Megow, D., Dirnagl, U., Weber, J. R., & Hörtnagl, H. (2001). Differential Mechanisms of Neuroprotection by 17 β-Estradiol in Apoptotic versus Necrotic Neurodegeneration. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.21-08-02600.2001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.